{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:11:00Z","timestamp":1790122260419,"version":"4.0.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T00:00:00Z","timestamp":1654560000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.ejps.2022.106234","type":"journal-article","created":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T02:21:12Z","timestamp":1654654872000},"page":"106234","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Lipid nanoparticle formulations for optimal RNA-based topical delivery to murine airways"],"prefix":"10.1016","volume":"176","author":[{"given":"A","family":"Tam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3622-6998","authenticated-orcid":false,"given":"J","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4733-2577","authenticated-orcid":false,"given":"K","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3876-608X","authenticated-orcid":false,"given":"L","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0680-0258","authenticated-orcid":false,"given":"DR","family":"Dorscheid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8422-0857","authenticated-orcid":false,"given":"GK","family":"Singhera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3198-1548","authenticated-orcid":false,"given":"P","family":"Bernatchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7567-3424","authenticated-orcid":false,"given":"GSD","family":"Reid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0515-3914","authenticated-orcid":false,"given":"KYT","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Witzigmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PR","family":"Cullis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DD","family":"Sin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6381-7585","authenticated-orcid":false,"given":"CJ","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2022.106234_bib0001","unstructured":"Anon, 2022 https:\/\/gisanddata.maps.arcgis.com\/apps\/opsdashboard\/index.html#\/bda7594740fd40299423467b48e9ecf6."},{"key":"10.1016\/j.ejps.2022.106234_bib0002","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA COVID-19 Vaccine","author":"Polack","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"20","key":"10.1016\/j.ejps.2022.106234_bib0003","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1056\/NEJMoa2022483","article-title":"An mRNA vaccine against SARS-CoV-2 - preliminary report","volume":"383","author":"Jackson","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejps.2022.106234_bib0004","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa2119451","article-title":"COVID-19 vaccine effectiveness aginst the Omicron (B.1.1.529) variant","volume":"386","author":"Andrews","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.ejps.2022.106234_bib0005","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/s41565-019-0591-y","article-title":"The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs","volume":"14","author":"Akinc","year":"2019","journal-title":"Nat. Nanotechnol."},{"issue":"7807","key":"10.1016\/j.ejps.2022.106234_bib0006","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","article-title":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor","volume":"581","author":"Lan","year":"2020","journal-title":"Nature"},{"issue":"7807","key":"10.1016\/j.ejps.2022.106234_bib0007","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41586-020-2179-y","article-title":"Structural basis of receptor recognition by SARS-CoV-2","volume":"581","author":"Shang","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ejps.2022.106234_bib0008","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-020-0868-6","article-title":"SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes","author":"Sungnak","year":"2020","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.ejps.2022.106234_bib0009","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1021\/acs.accounts.9b00368","article-title":"Lipid nanoparticle technology for clinical translation of siRNA therapeutics","volume":"52","author":"Kulkarni","year":"2019","journal-title":"Acc. Chem. Res."},{"issue":"11","key":"10.1016\/j.ejps.2022.106234_bib0010","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.3390\/pharmaceutics12111042","article-title":"Aerosolizable lipid nanoparticles for pulmonary delivery of mRNA through design of experiments","volume":"12","author":"Zhang","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2022.106234_bib0011","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/s41551-021-00786-x","article-title":"Optimization of lipid nanoparticles for the delivery of nebulized therapeutic mRNA to the lungs","volume":"5","author":"Lokugamage","year":"2021","journal-title":"Nat. Biomed Eng."},{"issue":"8","key":"10.1016\/j.ejps.2022.106234_bib0012","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2116271119","article-title":"Lung-selective mRNA delivery of synthetic lipid nanoparticles for the treatment of pulmonary lymphangioleiomyomatosis","volume":"119","author":"Qiu","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.ejps.2022.106234_bib0013","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejps.2022.106234_bib0014","doi-asserted-by":"crossref","DOI":"10.1152\/ajplung.00477.2020","article-title":"FAM13A as potential therapeutic target in modulating TGF-beta-induced airway tissue remodeling in COPD","author":"Tam","year":"2021","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"issue":"5","key":"10.1016\/j.ejps.2022.106234_bib0015","doi-asserted-by":"crossref","first-page":"4787","DOI":"10.1021\/acsnano.8b01516","article-title":"On the formation and morphology of lipid nanoparticles containing ionizable cationic lipids and siRNA","volume":"12","author":"Kulkarni","year":"2018","journal-title":"ACS Nano"},{"issue":"45","key":"10.1016\/j.ejps.2022.106234_bib0016","doi-asserted-by":"crossref","first-page":"21733","DOI":"10.1039\/C9NR09347H","article-title":"On the role of helper lipids in lipid nanoparticle formulations of siRNA","volume":"11","author":"Kulkarni","year":"2019","journal-title":"Nanoscale"},{"key":"10.1016\/j.ejps.2022.106234_bib0017","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jconrel.2016.05.059","article-title":"Influence of particle size on the in vivo potency of lipid nanoparticle formulations of siRNA","volume":"235","author":"Chen","year":"2016","journal-title":"J. Control Rel."},{"key":"10.1016\/j.ejps.2022.106234_bib0018","doi-asserted-by":"crossref","first-page":"23959","DOI":"10.1039\/D0NR06816K","article-title":"Spontaneous, solvent-free entrapment of siRNA within lipid nanoparticles","volume":"12","author":"Kulkarni","year":"2020","journal-title":"Nanoscale"},{"issue":"16","key":"10.1016\/j.ejps.2022.106234_bib0019","doi-asserted-by":"crossref","first-page":"5951","DOI":"10.1073\/pnas.85.16.5951","article-title":"Characterization of human tracheal epithelial cells transformed by an origin-defective simian virus 40","volume":"85","author":"Gruenert","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejps.2022.106234_bib0020","first-page":"1","article-title":"Naturally derived membrane lipids impact nanoparticle-based messenger RNA delivery","author":"Kim","year":"2020","journal-title":"Cell. Mol. Bioeng."},{"issue":"33","key":"10.1016\/j.ejps.2022.106234_bib0021","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6528\/ab8a8a","article-title":"Dual-targeted therapy in HER2-positive breast cancer cells with the combination of carbon dots\/HER3 siRNA and trastuzumab","volume":"31","author":"Shu","year":"2020","journal-title":"Nanotechnology"},{"issue":"2","key":"10.1016\/j.ejps.2022.106234_bib0022","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.molmed.2011.10.003","article-title":"CFTR: folding, misfolding and correcting the \u2206F508 conformational defect","volume":"18","author":"Lukacs","year":"2012","journal-title":"Trends Mol. Med."},{"issue":"35","key":"10.1016\/j.ejps.2022.106234_bib0023","doi-asserted-by":"crossref","first-page":"13682","DOI":"10.1074\/jbc.RA118.002607","article-title":"Silencing of the Hsp70-specific nucleotide-exchange factor BAG3 corrects the F508del-CFTR variant by restoring autophagy","volume":"293","author":"Hutt","year":"2018","journal-title":"J. Biol. Chem."},{"issue":"35","key":"10.1016\/j.ejps.2022.106234_bib0024","doi-asserted-by":"crossref","first-page":"13477","DOI":"10.1074\/jbc.RA118.003192","article-title":"Correcting the F508del-CFTR variant by modulating eukaryotic translation initiation factor 3-mediated translation initiation","volume":"293","author":"Hutt","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejps.2022.106234_bib0025","doi-asserted-by":"crossref","first-page":"12138","DOI":"10.1038\/srep12138","article-title":"Genetic Inhibition of the Ubiquitin Ligase Rnf5 Attenuates Phenotypes Associated to F508del Cystic Fibrosis Mutation","volume":"5","author":"Tomati","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejps.2022.106234_bib0026","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3389\/fmicb.2014.00226","article-title":"Epidemiology of virus-induced asthma exacerbations: with special reference to the role of human rhinovirus","volume":"5","author":"Saraya","year":"2014","journal-title":"Front. Microbiol."},{"issue":"11","key":"10.1016\/j.ejps.2022.106234_bib0027","doi-asserted-by":"crossref","first-page":"11778","DOI":"10.1021\/nn505399e","article-title":"Critical determinants of uptake and translocation of nanoparticles by the human pulmonary alveolar epithelium","volume":"8","author":"Thorley","year":"2014","journal-title":"ACS Nano"},{"issue":"3","key":"10.1016\/j.ejps.2022.106234_bib0028","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1089\/jamp.2011.0916","article-title":"Aerosol deposition in health and disease","volume":"25","author":"Darquenne","year":"2012","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"issue":"4","key":"10.1016\/j.ejps.2022.106234_bib0029","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","article-title":"Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR-Cas gene editing","volume":"15","author":"Cheng","year":"2020","journal-title":"Nat. Nanotechnol."},{"issue":"7","key":"10.1016\/j.ejps.2022.106234_bib0030","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.ymthe.2017.03.013","article-title":"Lipid nanoparticle systems for enabling gene therapies","volume":"25","author":"Cullis","year":"2017","journal-title":"Mol. Ther."},{"issue":"11","key":"10.1016\/j.ejps.2022.106234_bib0031","doi-asserted-by":"crossref","first-page":"5848","DOI":"10.1002\/anie.202013927","article-title":"A systematic study of unsaturation in lipid nanoparticles leads to improved mRNA transfection in vivo","volume":"60","author":"Lee","year":"2020","journal-title":"Angew. Chem. Int. Ed."},{"issue":"1\u20132","key":"10.1016\/j.ejps.2022.106234_bib0032","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.bbamem.2004.06.010","article-title":"Nonbilayer lipids affect peripheral and integral membrane proteins via changes in the lateral pressure profile","volume":"1666","author":"van den Brink-van der Laan","year":"2004","journal-title":"Biochim. Biophys. Acta Biomembr."},{"issue":"3","key":"10.1016\/j.ejps.2022.106234_bib0033","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/S0006-3495(03)74596-2","article-title":"Curvature and bending constants for phosphatidylserine-containing membranes","volume":"85","author":"Fuller","year":"2003","journal-title":"Biophys. J."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098722001191?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098722001191?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T12:01:53Z","timestamp":1760529713000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098722001191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":33,"alternative-id":["S0928098722001191"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2022.106234","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipid nanoparticle formulations for optimal RNA-based topical delivery to murine airways","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2022.106234","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106234"}}